Guizhou Bailing Group Pharmaceutical Co.,Ltd.’s Net Profit Rose 42.5% in First Half of 2023

Guizhou Bailing Group Pharmaceutical Co.,Ltd. (贵州百灵企业集团制药股份有限公司) (002424.SZ) reported a net profit of 121.8 million yuan in the first half of 2023, up 42.5% year-on-year.

Meanwhile, the company posted 1.9 billion yuan in revenue, up 48.1% year-on-year.

At the end of the reporting period, it had 7.2 billion yuan in total assets and 3.2 billion yuan in total liabilities, with a liability-to-asset ratio of 43.9%.